AAVAA has developed a technology that allows users to amplify the sounds they want to hear and not simply amplify all surrounding sounds. It allows interactivity with the device without the use of voice or hands. Through the sensors it has developed, the technology interprets brain signals and the platform allows for the decoding of attention based separately and/or combined on head movements, eye movements and eye blinks and then uses them as commands.
SE2 develops and markets Alice POS, a new-generation point-of-sale software designed for multi-site stores such as franchises, buying groups and corporate networks.
AmpMe is a company that has developed a mobile application to synchronize speakers from multiple smartphones and tablets to create the effect of a giant speaker.
AxesNetwork's mission is to provide a cashless payment and point-of-sale management solution as well as all operating reports in a scalable and secure environment in the small to medium sized casino market.
Bonlook designs and manufactures eyewear frames. Sales are made online and through boutiques in various shopping centers.
Boreas develops and markets smaller integrated circuits (electronic chips). Boreas' technology has been developed specifically for piezoelectric actuators and allows to exploit the potential of piezoelectric haptic technologies, i.e. tactile-kinesthetic systems present, for example, in smartphones.
Centrix offers accessible, affordable and effective customer relationship management and marketing software for small and medium-sized enterprises (SMEs).
ChrysaLabs develops and markets a technology for the instant analysis of agricultural soils by combining spectrometry technology and information processing. This solution, in the form of a probe, allows farmers and agronomists to know much more quickly the available soil nutrients, which facilitates decisions regarding fertilizer application. Compared to laboratory analysis, this technology reduces the cost of sampling and significantly reduces analysis time.
Clinia is a specialized search engine and directory for health. Clinia allows patients and care teams to navigate the healthcare system more efficiently and to have a targeted response to their needs. The product is a "white label" solution that integrates with Clinia's customers' systems via API. By combining Clinia's technology with its customers' data, Clinia is able to provide targeted search results to patients. Clinia's target and current customers are healthcare organizations and insurers. Clinia addresses a major issue for its clients and their patients.
Cobalt offers an enterprise risk management platform that automates the response process.
Depix's technology allows the rapid and photorealistic insertion of objects into images. Depix's mission is to democratize the creation of photorealistic images for non-technical users.
Elkimia is a chemical innovation company that has synthetically developed several chemical molecules on a class of mycosporin-like amino acids based on the mycosporins produced by algae.
Ethnocare aims to develop innovative products for prostheses to improve the quality of life of amputees and allow them to regain mobility.
Evey offers a digital personal assistance solution for your home. The solution consists of a device to be installed your home and integrates a software solution that enhances the occupants' experience. It allows one to perform tasks, get information, manage the schedule and control the home automation.
Extend AI develops a horizontal artificial intelligence platform that enables its clients to increase their ability to perceive, understand and optimize their physical work environment. The first vertical application of Extend AI's platform has been built for the natural stone industry ("Stone AI") through a strategic partnership with Polycor to improve their critical inspection and quality assurance process for this industry. With this AI platform, Extend intends to address other vertical markets, always in partnership with industry specialists, in the field of industrial automation, industrial space management and factories.
Feldan is a biotechnology company that has developed a patented peptide-based technology that allows for the rapid and safe introduction of proteins into human cells. The platform, named Feldan Shuttle, has been successfully used for ex vivo and in vivo applications.
Giiant is a preclinical biotechnology company with a targeted delivery platform, enabling it to develop small molecules for various therapeutic targets in gastroenterology, always with a gastrointestinal tract approach. Its lead drug, GT-2108, is a prodrug of a PDE4 inhibitor bioactivated by the gut microbiome, improving the tolerability and efficacy of the drug.
GrayOS has a vision of an oncology workflow where each patient's journey through cancer treatment is customized for them and statistically optimized to provide the best possible clinical outcomes. In pursuit of this vision, GrayOS resource allocation software focuses on optimizing the functional efficiency of entire cancer centers, resulting in reduced patient wait times, higher patient throughput, reduced stress, and ultimately superior patient care.
Haleo's platform consists of a clinically validated automated sleep screening tool, a mobile application with tools, including chat, video conferencing and a questionnaire system, to enable clients to access telepsychotherapy or self-treatment.
Hausvalet (ex-Zenit concept) has developed and started the commercialization of a virtual reality imaging service for the real estate brokerage industry.
Hexoskin is a platform for monitoring vital signs using connected objects. The platform provides the wearer with a multitude of high-quality biometric data in real time.
Imagia produces Deep Radiomics biomarkers from routine clinical imaging data (Deep Learning) to help healthcare professionals diagnose and predict patient response to treatment, disease progression and provide timely triggers for personalized diagnosis and therapy.
Impak’s mission is to help investors and lenders make more sustainable decisions by providing them with assessments that go beyond ESG and include both the negative and positive impacts of their assets, whether listed or private.
Intelia specializes in the design and sale of intelligent control systems that can manage all the equipment present in agricultural production buildings and that would be able to allow an optimization of the animal production process through the analysis of the collected data.
Inversago Pharma is a privately-held, clinical-stage Canadian biotechnology company focused on the development of innovative therapies targeting CB1 receptor inhibition through a novel class of peripherally active inverse agonists. The Company's ambition is to provide new therapeutic options that improve the lives of patients with metabolic conditions such as diabetic kidney disease (DKD), including diabetic nephropathy (DN), type 1 diabetes (T1DM) and type 2 diabetes (T2DM), non-alcoholic fatty liver disease (NASH), obesity-related complications, hypertriglyceridemia (HTG), as well as fibroses such as progressive interstitial fibrosis lung disease (PI-FLD), including idiopathic pulmonary fibrosis (IPF) and other indications.
IONODES is dedicated to the development of the latest technologies in video encoding, video decoding and video content management devices and their software platforms.
Kalgene is actively developing a drug to fight Alzheimer's disease. The company intends to develop a drug that would be efficiently delivered to the brain and would be able to capture AB42 and attack the AB42 plaques to eliminate them.
Keatext has developed an AI-based Customer Feedback Management platform that allows brands to better understand their customers' feedback on e-commerce sites (Amazon, Walmart, Google, brand site) where the brand is sold. The platform allows to take action and improve the customer experience.
Laurent Pharmaceuticals is developing a drug, LAU-7b, for the treatment of chronic inflammation in people with cystic fibrosis (CF).
Lexop has developed software to help large and medium-sized companies better collect past due accounts receivable by providing paying users with more flexibility and ease in settling their accounts than traditional methods currently in place.
Maxa is an advanced data automation and analytics platform for enterprise resource planning (ERP) systems targeting mid-market companies (50M to 1B in revenue). Maxa enables its customers to leverage the data in their ERP systems and deploy Predictive Monitoring, Automated Forecasting and AI Analytics applications. Maxa is particularly targeted at financial managers and P&L managers of companies or business units.
Merinio develops and markets a software (SaaS) that allows service companies to optimize their schedule management and automates part of the shift planning process.
MIMs, for "My Intelligent Machines," is a platform capable of helping life science companies use massive data and artificial intelligence (AI) to create more efficient medicine and agriculture. MIMS' platform will allow for the classification of patients and the determination of good responders to a target treatment. The software is also capable of predicting drug response and biomarker discovery.
Mogo (ex-Mylo) is a Fintech firm that offers the ability for its customers, users of its mobile app, to round up their daily purchases to save and invest the difference. Mylo was acquired by MOGO, which empowers consumers with simple solutions to help them manage and control their finances.
Myni aims to create and promote products that are safe for the planet and for people, but above all simple and pleasant to use. The company manufactures and markets cleaning and body care products in tablet or powder form which, when dissolved in water, transforms into a conventional household or body care product.
Noze (ex-Stratuscent) is a company focused on artificial intelligence (AI) applied to chemical detection and quantification equipment (artificial nose). It is based on proven technology licensed from NAS
Oneka Technologies designs and manufactures a desalination system that produces drinking water using wave energy. The modular system of buoys equipped with an osmosis pump allows multiple buoys to be grouped together to meet the volume needs of its customers.
Ovensa is developing a nano-therapeutic molecule to improve the bioavailability of active drugs, the protection of these drugs during their transport to the targeted cells and a better targeting of the treatments.
PivoHub develops and markets an e-commerce platform for the agri-food industry, specializing in long-tail suppliers and with a reputation in Quebec in the microbrewery niche.
Pivot88 develops software to improve the process of quality control and supply chain management with overseas subcontractors for customers who manufacture high-volume, consumer goods that require multiple quality checks and tight delivery times.
Polystyvert is an environmental company that develops an innovative technology to recycle styrenic plastics and in particular polystyrene in circular economy. This dissolution recycling technology has a positive impact on water, air and soil.
Puzzle Medical Devices is a medical device company developing a minimally invasive, intra-aortic ventricular assist pump for patients with reduced cardiac function who require acute or chronic assistance. A ventricular assist device (VAD) is an artificial heart pump used for severe heart failure. An implantable device with a power supply and external control console can be used to provide assistance to the left ventricle. This device replaces the pumping function of the heart until a graft is available to perform a heart transplant.
Revelate's data processing platform provides a suite of capabilities for sharing and marketing large amounts of "Big Data". The platform is aimed at all companies that generate very large amounts of data and have the desire to monetize it.
Saguaro offers next-generation cell culture products that help scientists improve drug discovery success.
SigNum intends to bring to market a non-intrusive method of capturing and recording electrocardiograms (ECGs). The company has developed a sensor technology, incorporated into a pad, which does not require contact with the patient's skin.
SportlogIQ's objective is to develop an automated platform for sports statistical data analysis. SportlogIQ has relied on artificial intelligence and optical recognition to develop its automated data processing solution platform. Currently, it is marketing and further developing its platform for the extraction and analysis of data from available video tapes.
Intuitic Inc (Studyo) has developed and markets a mobile and web application, sold as subscriptions mainly to schools, aimed at developing organizational skills in students by allowing students to write down their own deadlines or to plan, annotate or subdivide projects proposed by their teachers.
Thorasys has developed a portable medical device (TremoFlo) for the detection of lung diseases based on oscillometry methodology.
Trexity builds a platform designed to provide a marketplace between drivers and merchants, all to the benefit of last-mile delivery for customers. Trexity was created to simplify the logistics of last-mile delivery to support local merchants and enable them to compete with the e-commerce giants.
UGroupMedia s the proud producer of PNP - Portable North Pole, a global family entertainment property that brings the magic of personalized video content alive with our cutting-edge technology.
WEGOTRADE is an order-taking platform offered to suppliers (wholesalers, processors, distributors, agents, etc.) and buyers (retailers) to automate their transactions in a mobile way.
AQC Capital is truly a committed VC. You can really sense, both in their words and in their actions, that they have the company's success at heart, both in terms of its international reach, and its local reach.
At the start of the company, I was well trained in drug development, but these were my first rounds of investment.
Their guidance and our interactions allowed me to ask questions that were important to me, and to better understand the dynamics of corporate finance.
For me, it was truly a period of challenge. They "challenged" me on my business model, allowed me to go further in my strategic analysis, and they still allow me to do so today.
The members of the AQC Capital team were good ambassadors and representatives of the company, supporting us in preparing for the rounds and making it clear to the other investors who we really were. It really helped us close our final rounds.
They helped me really understand the other side of the coin or how corporate investors think... It helped me better negotiate certain terms with future investors, which worked in our favor in many ways.
